CLOROX CO /DE/ (CLX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Annual

0 3B 6B 9B FY10: 5.2B FY11: 5.2B FY12: 5.5B FY13: 5.6B FY14: 5.5B FY15: 5.7B FY16: 5.8B FY17: 6B FY18: 6.1B FY19: 6.2B FY20: 6.7B FY21: 7.3B FY22: 7.1B FY23: 7.4B FY24: 7.1B FY25: 7.1B FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 1.5B 3B 4.5B FY08: 2.2B FY09: 2.2B FY10: 2.3B FY11: 2.3B FY12: 2.3B FY13: 2.4B FY14: 2.4B FY15: 2.5B FY16: 2.6B FY17: 2.7B FY18: 2.7B FY19: 2.7B FY20: 3.1B FY21: 3.2B FY22: 2.5B FY23: 2.9B FY24: 3B FY25: 3.2B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Annual

0 350M 700M 1.1B FY08: 461M FY09: 537M FY10: 603M FY11: 557M FY12: 541M FY13: 572M FY14: 558M FY15: 580M FY16: 648M FY17: 701M FY18: 823M FY19: 820M FY20: 939M FY21: 710M FY22: 462M FY23: 149M FY24: 280M FY25: 810M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 2B 4B 6B FY16: 3.2B FY17: 3.3B FY18: 3.4B FY19: 3.5B FY20: 3.7B FY21: 4.1B FY22: 4.6B FY23: 4.5B FY24: 4B FY25: 3.9B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

0 600M 1.2B 1.8B FY08: 730M FY09: 738M FY10: 819M FY11: 698M FY12: 612M FY13: 775M FY14: 767M FY15: 874M FY16: 778M FY17: 865M FY18: 976M FY19: 992M FY20: 1.5B FY21: 1.3B FY22: 786M FY23: 1.2B FY24: 695M FY25: 981M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 500M 1B 1.5B FY08: 560M FY09: 542M FY10: 618M FY11: 470M FY12: 420M FY13: 585M FY14: 630M FY15: 749M FY16: 606M FY17: 634M FY18: 782M FY19: 786M FY20: 1.3B FY21: 945M FY22: 535M FY23: 930M FY24: 483M FY25: 761M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 50M 100M 150M FY08: 141.2M FY09: 140.2M FY10: 141.5M FY11: 138.1M FY12: 132.3M FY13: 133M FY14: 131.7M FY15: 132.8M FY16: 131.7M FY17: 131.6M FY18: 131.6M FY19: 129.8M FY20: 127.7M FY21: 127.3M FY22: 123.9M FY23: 124.2M FY24: 124.8M FY25: 124.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.50 7.00 10.50 Q1 '10: 4.00 Q2 '10: 4.16 Q3 '10: 4.24 Q4 '10: 4.24 Q1 '11: 4.65 Q2 '11: 4.03 Q3 '11: 3.96 Q4 '11: 4.02 Q1 '13: 4.13 Q2 '13: 4.27 Q3 '13: 4.26 Q4 '13: 4.31 Q1 '14: 4.33 Q2 '14: 4.27 Q3 '14: 4.31 Q4 '14: 4.23 Q1 '15: 3.88 Q2 '15: 3.96 Q3 '15: 4.22 Q4 '15: 4.39 Q1 '16: 5.02 Q2 '16: 5.20 Q3 '16: 5.13 Q4 '16: 4.93 Q1 '17: 4.98 Q2 '17: 4.99 Q3 '17: 5.07 Q4 '17: 5.33 Q1 '18: 5.43 Q2 '18: 6.06 Q3 '18: 6.12 Q4 '18: 6.26 Q1 '19: 6.42 Q2 '19: 6.05 Q3 '19: 6.12 Q4 '19: 6.34 Q1 '20: 6.31 Q2 '20: 6.37 Q3 '20: 6.82 Q4 '20: 7.35 Q1 '21: 8.98 Q2 '21: 9.55 Q3 '21: 7.17 Q4 '21: 5.54 Q1 '22: 3.46 Q2 '22: 1.99 Q3 '22: 3.69 Q4 '22: 3.73 Q1 '23: 3.27 Q2 '23: 3.51 Q3 '23: 0.59 Q4 '23: 1.20 Q1 '24: 0.69 Q2 '24: 0.64 Q3 '24: 1.94 Q4 '24: 2.24 Q1 '25: 2.87 Q2 '25: 3.66 Q3 '25: 5.57 Q4 '25: 6.52 Q1 '26: 6.37 Q2 '26: 6.12 Q3 '26: 6.16 Q3 '11 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.